Santhera Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingBasel-Landschaft, Switzerland51-200 Employees
Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company based in Pratteln, in the Basel-Landschaft region, with 51-200 employees and listed on the SIX Swiss Exchange (SANN). The company focuses on the development and commercialization of medicines for rare neuromuscular diseases with high unmet medical need. It holds an exclusive worldwide license from ReveraGen for AGAMREE (vamorolone), a dissociative steroid with a novel mode of action, evaluated in Duchenne muscular dystrophy. AGAMREE has regulatory approvals in the United States, the European Union, the United Kingdom, China, Hong Kong, and Canada. Santhera has out-licensed rights to AGAMREE for North America to Catalyst Pharmaceuticals and for China and certain Southeast Asia countries to Sperogenix Therapeutics.